Drug Shortage Report for SABRIL
| Report ID | 164487 |
| Drug Identification Number | 02068036 |
| Brand name | SABRIL |
| Common or Proper name | vigabatrin powder for oral solution |
| Company Name | LUNDBECK PHARMACEUTICALS LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | VIGABATRIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | Cartons of 50 |
| ATC code | N03AG |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2022-09-07 |
| Actual start date | 2022-09-08 |
| Estimated end date | 2023-03-22 |
| Actual end date | 2023-03-22 |
| Shortage status | Resolved |
| Updated date | 2024-05-13 |
| Company comments | Very limited orders (432 unites) for the US-labelled Sabril for Oral Solution can be placed through Ashfield Healthcare. Pharmacies can register with Ashfield Healthcare by emailing [email protected] or calling 1-514-630-7484 and referencing the Lundbeck Sabril Program. The pharmacy will be required to provide their full address and license number. Once registered, Ashfield will send out a weekly solicitation to all pharmacies in network with instructions on how to order the product |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SIX PARKWAY NORTH, SUITE 400 DEERFIELD, ILLINOIS UNITED STATES 60015 |
| Company contact information | 1-866-880-4636 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2022-08-30 | English | Compare |
| v12 | 2022-08-17 | French | Compare |
| v11 | 2022-08-17 | English | Compare |
| v10 | 2022-08-16 | English | Compare |
| v9 | 2022-08-02 | French | Compare |
| v8 | 2022-08-02 | English | Compare |
| v7 | 2022-08-02 | English | Compare |
| v6 | 2022-07-13 | French | Compare |
| v5 | 2022-07-13 | English | Compare |
| v4 | 2022-07-13 | English | Compare |
| v3 | 2022-07-13 | English | Compare |
| v2 | 2022-07-13 | English | Compare |
| v1 | 2022-07-12 | English | Compare |